Regarding ALS, it has been described that NRF2 mRNA and protein levels were reduced in ALS patients relative to control tissues, [38,39], but NRF2-dependent genes were not evaluated. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.